Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results

[Business Wire] – Opexa Therapeutics, Inc. , a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis , today announced that the Company will report financial results for the year ended December 31 more

View todays social media effects on OPXA

View the latest stocks trending across Twitter. Click to view dashboard

See who Opexa is hiring next, click here to view